MY156332A
(en )
2016-02-15
Quinuclidine carbonate derivatives and medicinal composition thereof
MY150823A
(en )
2014-02-28
Alkaloid aminoester derivatives and medicinal composition thereof
IN2012DN02735A
(fr )
2015-09-11
IN2012DN02730A
(fr )
2015-09-11
IN2012DN00754A
(fr )
2015-06-19
AU2011234398A8
(en )
2015-03-05
Novel NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
SG10201907588XA
(en )
2019-09-27
Androgen Receptor Modulators And Uses Thereof
WO2012088038A3
(fr )
2012-10-26
Antagonistes de mch-1 consistant en tétrahydro-carbolines substituées par pipérazinone, leurs procédés de fabrication et utilisations
JO3078B1
(ar )
2017-03-15
مورفولينوثيازولات بصفتها منظمات الوستيرية نوع الفا 7 موجبة
TN2012000161A1
(en )
2013-12-12
Spiro-oxindole mdm2 antagonists
WO2011017108A3
(fr )
2011-06-03
Modulateurs cyclopropylés du récepteur p2y12
MY163055A
(en )
2017-08-15
Polycyclic antagonists of lysophosphatidic acid receptors
MX348823B
(es )
2017-06-30
Formulaciones estables de linaclotida.
EP4268814A3
(fr )
2024-01-24
Composition pharmaceutique pour le traitement de l'oeil sec
MX2019012939A
(es )
2019-12-16
Formulaciones que contienen linaclotida para administracion oral.
WO2012088124A3
(fr )
2012-08-16
Antagonistes de la mch-1 à base de tétrahydro-azacarboline, leurs procédés de fabrication et leurs utilisations
GEP20166450B
(en )
2016-03-25
Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same
TN2012000488A1
(en )
2014-04-01
Pharmaceutical compositions comprising hydromorphone and naloxone
IL217759A
(en )
2015-09-24
Pyrolidine derivatives as 3nk receptor antagonists, pharmaceuticals containing them, process for preparation, and use thereof for drug preparation
EP2568810A4
(fr )
2013-12-04
Compositions de darunavir
TN2011000063A1
(en )
2012-09-05
Quinuclidine carbonate derivatives and medicinal composition thereof
UA96037C2
(ru )
2011-09-26
Применение антагониста рецепторов интерлейкина-1 как средства антиалкогольного действия